Healthcare

Neuren Pharmaceuticals Ltd (ASX:NEU) traded modestly higher during the afternoon trading session on 14 July 2026, with its shares rising 0.061% to AUD 16.51. The company has also maintained a positive longer-term performance, remaining up 14.87% over the past year.

What follows is a balanced, general overview of the company and its setting, including possible drivers of the move and the uncertainties that investors may wish to weigh for themselves. It does not constitute financial advice.

Cochlear Limited (ASX:COH) shares traded higher during the latest trading session, rising 1.48% to AUD 123.100 from the previous close of AUD 121.300. The healthcare company recorded steady trading activity as investors monitored movements in the stock throughout the session. During the day, the …

Sonic Healthcare Limited (ASX:SHL) shares traded higher during the latest trading session, rising 1.48% to AUD 21.240 from the previous close of AUD 20.930. The healthcare company recorded a positive trading session as investors monitored activity on the Australian Securities Exchange. During the day, …

• CurveBeam AI shares climbed6.25%toAUD 0.017during the trading session.• Trading turnover reached approximatelyAUD 16,956.• The company has a market capitalisation of approximatelyAUD 8.23 million.• Shares remain75.71% lower over the past 12 monthsdespite the latest rebound.• Investors continue monitoring growth opportunities in artificial intelligence and …

• Firebrick Pharma shares climbed7.14%toAUD 0.03during the session.• Trading turnover reached approximatelyAUD 9,196.• The company has a market capitalisation of approximatelyAUD 8.56 million.• Shares remain52.38% lower over the past yeardespite the latest rally.• Investors continue monitoring commercialisation opportunities for the company's lead product portfolio.

• Vitura Health shares climbed7.14%toAUD 0.03during the session.• Trading turnover reached approximatelyAUD 1,473.• The company has a market capitalisation of approximatelyAUD 19.88 million.• The stock remains53.13% lower over the past yeardespite the latest rebound.• Investors continue monitoring growth opportunities across telehealth and digital healthcare …